Scenarios

Choose the correct lifecycle operation for an updated document

Know what must happen after accelerated approval

Choose DCP or MRP based on whether you already have an MA

Pick the best content for a 483 response

Classify a protocol change in the EU

Pick the best FDA meeting type for a narrow question set

Know how applicants reference confidential DMF information

Choose the right reduced stability design concept

Decide how to classify a post-approval change in the EU

When can you start dosing under an IND?